View Older Stories View More Recent Stories

Jul 2, 2014 09:27AM Roth Reinstates BioLineRx (BLRX) at 'Buy'; Strong Pipeline Reinforces Upside Potential
Jul 2, 2014 08:44AM Roth Capital Resumes BioLineRx (BLRX) at Buy
Jun 29, 2014 02:41AM Medigus Announces Signing of $11.1 Million Private Placement by Leading Israeli and U.S. Institutions
Jun 27, 2014 09:06AM Roth Capital Remains Positive on Stemline (STML); Management Updates on SL-401, SL-701
Jun 27, 2014 08:05AM IGI Labs (IG) Prices 4.65M Common Offering at $5 Apiece
Jun 27, 2014 06:51AM Roth Capital Starts Dot Hill (HILL) at Buy
Jun 26, 2014 04:09PM IGI Laboratories (IG) Annouces Stock Offering
Jun 26, 2014 07:52AM Slow Ramp Leaves R-22 Pricing Flat; Roth Keeps Hudson Tech (HDSN) at 'Buy'
Jun 25, 2014 03:42PM Roth Capital Keeps LIgand Pharma (LGND) at Buy; Glaxo Initiates Promacta Phase III
Jun 25, 2014 08:57AM Wunderlich Expands into Consumer and Business Services Investment Banking
Jun 25, 2014 06:39AM Roth Capital Starts Concur Technologies (CNQR) at Buy
Jun 24, 2014 09:34AM Roth 'Encouraged' by TG Therapeutics (TGTX), Ligand (LGND) Deal; Issues Commentary
Jun 24, 2014 06:58AM Roth Affirms Hydrogenics (HYGS) at Buy; JV with Kolon Water is Step in Right Direction
Jun 23, 2014 12:04PM Streetinsider.com's Hot Lunchtime Reads 06/23: (MSFT) (LGND) (RSH) (YELP)
Jun 23, 2014 11:28AM Roth Capital Comments on New SERM Lasofoxifene Phase 1 Data
Jun 20, 2014 01:04PM Unusual 11 Mid-Day Movers 06/20: (KMX) (FLML) (CARA) Higher; (MACK) (PVCT) (CLRX) Lower
Jun 18, 2014 12:29PM SolarCity (SCTY) Continues Higher Following Silevo Deal, Management Commentary
Jun 18, 2014 07:14AM Roth Capital Starts Prosensa (RNA) at Neutral
Jun 18, 2014 06:51AM Roth Capital Starts Superior Drilling Products (SDPI) at Buy
Jun 18, 2014 06:19AM Roth Boosts Target on SolarCity (SCTY) to $80; Silevo Acquisition 'Makes Sense'
Jun 17, 2014 04:16PM Yingli Green Energy (YGE) Could See H214 Ramp; Roth Capital Keeps at 'Neutral'
Jun 17, 2014 12:36PM Roth 'Impressed' at Early Completion of Enrollment in Galena's (GALE) GALE-301 Phase 2a; Keeps at 'Buy'
Jun 17, 2014 08:54AM UPDATE: Short-Seller Article on Ligand (LGND) is Silly, Underlying Strength Remains - Roth Capital
Jun 16, 2014 10:28AM LGD-6972 Could Drive Partnership; Roth Keeps Ligand Pharma (LGND) at 'Buy'
Jun 13, 2014 11:20AM New Promacta Data Should Support Approval for cITP; Roth has Ligand (LGND) at 'Buy'
Jun 13, 2014 11:13AM Roth 'Encouraged' by TG Therapeutics' (TGTX) TG-1101 Phase 2 Prelim Results; Boosts PT to $20
Jun 13, 2014 10:33AM Notable Analyst Rating Changes 06/13: (INTC) (GEF) (NMBL) Upgraded; (MRVL) (LULU) (MRO) Downgraded
Jun 13, 2014 09:30AM Pre-Open Stock Movers 6/13: (OPEN) (EXPR) (ICLD) Higher; (FNSR) (OCLS) (ETRM) Lower (more...)
Jun 13, 2014 09:22AM Roth Capital Starts Conatus Pharmaceuticals (CNAT) at Buy
Jun 13, 2014 06:39AM Roth Capital Upgrades Intel (INTC) to Buy
Jun 13, 2014 06:37AM Roth Capital Starts Fusion-io (FIO) at Buy
Jun 13, 2014 06:35AM Worst of Capstone Turbine (CPST) Probably Priced in; Roth Affirms 'Buy' Rating
Jun 12, 2014 11:10AM Roth Comments on Regeneron (REGN), Sanofi Presentation of Sarilumab Phase 3 Data; Affirms at 'Buy'
Jun 11, 2014 11:27AM Roth Comments on Regeneron's (REGN) MAA Submission for EYLEA to EU; Reaffirms 'Buy' Rating
Jun 11, 2014 07:56AM Roth Positive on TG Therapeutics (TGTX) into EHA Presentation
Jun 10, 2014 10:41AM Roth Affirms 'Buy' Rating on MEI Pharma (MEIP); New AML Treatment Data Bolsters Confidence
Jun 10, 2014 09:38AM Roth Halves PT on Dendreon (DNDN) to 50c; Things Aren't Shaping Up Nicely
Jun 9, 2014 10:20AM Roth Keeps Pharmacyclics (PCYC) at 'Buy'; Imbruvica sNDA Selected for Priority Review by FDA
Jun 9, 2014 07:28AM Roth Capital Starts MacroGenics (MGNX) at Buy
Jun 5, 2014 07:42PM Marrone Bio Innovations Announces Pricing of Follow-on Offering
Jun 5, 2014 04:08PM Hudson Technologies, Inc. (HDSN) Plans Common Stock Offering
Jun 4, 2014 04:23PM Culture Still Intact at Curis (CRIS) Following Management Shift; Roth Affirms at 'Buy'
Jun 4, 2014 10:10AM LeMaitre Vascular, Inc. Closes Public Offering of Common Shares
Jun 4, 2014 09:54AM Roth Comments on DoC Prelim. Countervailing Duties (SCTY) (SPWR) (FSLR) (YGE)
Jun 4, 2014 08:08AM Pharmacyclics (PCYC) KOL Event at ASCO Impresses Physicians; Roth Keeps at 'Buy'
Jun 3, 2014 09:42AM ORR in Sunesis Pharma's (SNSS) Vosaroxin + Decitabine Phase III Improves; Roth Affirms 'Buy' Rating
Jun 3, 2014 07:44AM Synta (SNTA) Management Ready to Take Company to Next Level; Roth Affirms 'Buy' Rating
Jun 3, 2014 07:29AM Roth Keeps Celldex (CLDX) at 'Focus Pick'; Strong Phase I Data for Varlilumab Only Adds to Story
Jun 2, 2014 11:55AM Cytokinetics (CYTK) BENEFIT-ALS Update 'Encouraging'; Roth Maintains 'Buy' Rating
Jun 2, 2014 11:16AM Roth Still Positive on Galena Biopharma (GALE) Following GALE-301 FBP Presentation; Issues Commentary
View More Recent Stories View Older Stories